Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Zyrexindo Mandiri Buana Tbk. (ZYRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp222 (market cap 308B, 129.5K 24h volume), while Zyrexindo Mandiri Buana Tbk. trades at Rp129 (market cap 170.67B, 1.24M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Zyrexindo Mandiri Buana Tbk. is more actively traded (1.24M versus 129.5K). Which is the better fit depends on your goals.
| DGNS | ZYRX | |
|---|---|---|
Market Cap | 308B | 170.67B |
Volume | 129.5K | 1.24M |
Lot | 1.3K | 12.36K |
Turnover | 28.69M | 159.37M |
Average Price | 221.54 | 128.9 |
Value | 28.69M | 159.37M |
Indicative Equilibrium Price | 230 | 129 |
Indicative Equilibrium Volume | 110 | 233 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Zyrexindo Mandiri Buana Tbk.
PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Read more on ZYRX →
